News

MedEvolve Rated Top Revenue Cycle Management Workflow Optimization and Automation Solution, 2023 Black Book RCM Client Survey

NEW YORK, NY / ACCESSWIRE / November 30, 2023 / Black Book Research announces that MedEvolve has been named the…

2 years ago

iZafe Group presented at Stora Aktiedagarna

STOCKHOLM, SWEDEN / ACCESSWIRE / November 30, 2023 / iZafe Group (STO:IZAFE-B) iZafe Group's CEO, Anders Segerström, presented the company…

2 years ago

New Number of Shares and Votes in Senzime AB (publ)

UPPSALA, SWEDEN / ACCESSWIRE / November 30, 2023 / Senzime (STO:SEZI) The number of shares and votes in Senzime AB…

2 years ago

Fred Says Announces Annual Giving on World AIDS Day

CHICAGO, IL / ACCESSWIRE / November 30, 2023 / On Dec. 1, World AIDS Day, Fred Says announced it is…

2 years ago

Johnson & Johnson MedTech Acquires Laminar, Inc.

Innovative investigational device designed for Left Atrial Appendage Elimination (LAAX) to reduce the risk of stroke in patients with non-valvular…

2 years ago

MEDITECH Vice Chairman Howard Messing Honored With the CHIME Foundation Industry Leader Award

The healthcare IT pioneer and longtime MEDITECH CEO was recognized for his outstanding contributions to the industry and the CHIME…

2 years ago

Bright Uro Announces $23M Series A Funding Round Led by Laborie – Expands Senior Leadership Team to Accelerate Next Phase of Commercialization

Company Names Chief Product Development Officer and Chief Commercial Officer as Glean continues to progress to regulatory clearanceIRVINE, Calif.--(BUSINESS WIRE)--Bright…

2 years ago

Sensor Receives Conditional Approval

Toronto, Ontario--(Newsfile Corp. - November 30, 2023) - Sensor Technologies Corp. (CSE: SENS) (the "Company" or "Sensor") is pleased to…

2 years ago

FSD Pharma Inc. and Celly Nutrition Corp. Announce Completion of Plan of Arrangement

TORONTO, ON / ACCESSWIRE / November 30, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company) and Celly…

2 years ago

Jaguar Health to Present December 5 at the MedInvest Oncology Investor Conference

Top line data for Jaguar Health's pivotal phase 3 OnTarget trial of crofelemer for prophylaxis of diarrhea in adult cancer…

2 years ago